» Articles » PMID: 30333113

Evidence of Burnout in Health-system Pharmacists

Overview
Date 2018 Oct 19
PMID 30333113
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Results of a study to determine levels of and risk factors for professional burnout among health-system pharmacists are reported.

Methods: The Maslach Burnout Inventory Human Services Survey (MBI-HSS) was distributed to a target population of health-system pharmacists to assess study participants for burnout, which is characterized by feelings of emotional exhaustion, depersonalization, and reduced personal accomplishment. Health-system pharmacists were solicited via email through a professional network listserver to complete an anonymous, electronic questionnaire regarding burnout. Demographic information, employment characteristics, and responses to the MBI-HSS were collected using a cross-sectional cohort survey methodology. Descriptive statistics were used to assess MBI-HSS scores and risk factors associated with burnout.

Results: Of the 371 survey responses received, 329 were complete and included in the final analysis. Overall, 175 study participants (53.2%) reported scores indicating a high degree of burnout on at least 1 subscale of the MBI-HSS. Twenty-eight respondents (8.5%) had scores indicating burnout on all 3 subscales. Average scores were 22.9, 6.2, and 36.3 for feelings of emotional exhaustion, depersonalization, and reduced personal accomplishment, respectively. Modifiable and nonmodifiable risk factors for burnout were identified. The findings warrant further research on burnout prevention and action to promote resilience in the profession.

Conclusion: Half of health-system pharmacists assessed using the MBI-HSS in this study identified themselves as being at risk for burnout.

Citing Articles

"Internet+" pharmacy in psychiatric hospital amid COVID-19 and post-pandemic period: analysis and development.

Xie W, Wang F, Qian Y, Qiu L, Zhou Q, Shen Y Front Psychiatry. 2025; 15:1434966.

PMID: 39758438 PMC: 11695406. DOI: 10.3389/fpsyt.2024.1434966.


Barriers and facilitators to the implementation of screening and intervention for co-use of opioid medications and alcohol among community pharmacy patients.

Broussard G, Hohmeier K, Field C, Gordon A, Carlston K, Cernasev A J Subst Use Addict Treat. 2024; 169:209606.

PMID: 39672335 PMC: 11769736. DOI: 10.1016/j.josat.2024.209606.


A holistic approach to sustain and support lifelong practices of wellness among healthcare professionals: generating preliminary solid steps towards a culture of wellness.

Argus-Calvo B, Clegg D, Francis M, Dwivedi A, Carrola P, Leiner M BMC Med Educ. 2024; 24(1):1364.

PMID: 39587574 PMC: 11590568. DOI: 10.1186/s12909-024-06353-7.


Performance, interpersonal relationships and professional satisfaction: determinants to support pharmaceutical reengineering.

de Castro Araujo-Neto F, Dosea A, Pereira de Lyra-Jr D Explor Res Clin Soc Pharm. 2024; 15:100497.

PMID: 39263194 PMC: 11388773. DOI: 10.1016/j.rcsop.2024.100497.


Resilience and empathy in pharmacy interns: Insights from a three-year cohort study.

Halimi S, Mirzaei A, Rowett D, Whitfield K, Luetsch K Explor Res Clin Soc Pharm. 2023; 12:100333.

PMID: 37823011 PMC: 10562191. DOI: 10.1016/j.rcsop.2023.100333.